This announcement is a separate document:
方達控股：關連交易 - 向方達控股公司的控股股東出售泰格新澤醫藥技術（嘉興）有限公司之45%股權
Frontage Holdings Corporation: CONNECTED TRANSACTION - SALE OF 45% EQUITY INTEREST IN TIGER-XINZE MEDICAL TECHNOLOGY (JIAXING) CO., LTD. TO THE CONTROLLING SHAREHOLDER OF FRONTAGE HOLDINGS CORPORATION
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.